Kabra Drugs fundamental analysis
KABRADG
29.47
0.83 (2.90%)Last updated on 3 Feb, 2026 | 15:29 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Kabra Drugs Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
65.19
Sector P/B
1.28
Sec. Div. Yield
0.58
Kabra Drugs Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 65.19. Its P/B Ratio stands at 0, while the sector’s is 1.28. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.58%.
Kabra Drugs Score Card
Price
Expensive
Growth
Poor
Quality
Poor
Management
Poor
On its scorecard, Kabra Drugs reflects: Price – Expensive, Growth – Poor, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.
